These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27167729)

  • 1. Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4.
    Akinci G; Topaloglu H; Akinci B; Onay H; Karadeniz C; Ergul Y; Demir T; Ozcan EE; Altay C; Atik T; Garg A
    Eur J Med Genet; 2016 Jun; 59(6-7):320-4. PubMed ID: 27167729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.
    Shastry S; Delgado MR; Dirik E; Turkmen M; Agarwal AK; Garg A
    Am J Med Genet A; 2010 Sep; 152A(9):2245-53. PubMed ID: 20684003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
    Rajab A; Straub V; McCann LJ; Seelow D; Varon R; Barresi R; Schulze A; Lucke B; Lützkendorf S; Karbasiyan M; Bachmann S; Spuler S; Schuelke M
    PLoS Genet; 2010 Mar; 6(3):e1000874. PubMed ID: 20300641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy.
    Ardissone A; Bragato C; Caffi L; Blasevich F; Maestrini S; Bianchi ML; Morandi L; Moroni I; Mora M
    BMC Med Genet; 2013 Sep; 14():89. PubMed ID: 24024685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mutation in the
    Mancioppi V; Daffara T; Romanisio M; Ceccarini G; Pelosini C; Santini F; Bellone S; Mellone S; Baricich A; Rabbone I; Aimaretti G; Akinci B; Giordano M; Prodam F
    Front Endocrinol (Lausanne); 2023; 14():1212729. PubMed ID: 37501786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital generalized lipodystrophy type 4 due to a novel PTRF/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution.
    Adiyaman SC; V Schnurbein J; De Laffolie J; Hahn A; Siebert R; Wabitsch M; Kamrath C
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):946-952. PubMed ID: 35405042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and other morbid complications in congenital generalized lipodystrophy type 4.
    Akinci G; Alyaarubi S; Patni N; Alhashmi N; Al-Shidhani A; Prodam F; Gagne N; Babalola F; Al Senani A; Muniraj K; Elsayed SM; Beghini M; Saydam BO; Allawati M; Vaishnav MS; Can E; Simsir IY; Sorkina E; Dursun F; Kamrath C; Cavdar U; Chakraborty PP; Dogan OA; Al Hosin A; Al Maimani A; Comunoglu N; Hamed A; Huseinbegovic T; Scherer T; Curtis J; Brown RJ; Topaloglu H; Simha V; Wabitsch M; Tuysuz B; Oral EA; Akinci B; Garg A
    Am J Med Genet A; 2024 Jun; 194(6):e63533. PubMed ID: 38234231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.
    Dwianingsih EK; Takeshima Y; Itoh K; Yamauchi Y; Awano H; Malueka RG; Nishida A; Ota M; Yagi M; Matsuo M
    Mol Genet Metab; 2010; 101(2-3):233-7. PubMed ID: 20638880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.
    Akinci B; Onay H; Demir T; Ozen S; Kayserili H; Akinci G; Nur B; Tuysuz B; Nuri Ozbek M; Gungor A; Yildirim Simsir I; Altay C; Demir L; Simsek E; Atmaca M; Topaloglu H; Bilen H; Atmaca H; Atik T; Cavdar U; Altunoglu U; Aslanger A; Mihci E; Secil M; Saygili F; Comlekci A; Garg A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2759-67. PubMed ID: 27144933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study.
    Akinci G; Topaloglu H; Demir T; Danyeli AE; Talim B; Keskin FE; Kadioglu P; Talip E; Altay C; Yaylali GF; Bilen H; Nur B; Demir L; Onay H; Akinci B
    Neuromuscul Disord; 2017 Oct; 27(10):923-930. PubMed ID: 28754454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nonsense mutation in the PTRF gene underlies congenital generalized lipodystrophy in a consanguineous Saudi family.
    Jelani M; Ahmed S; Almramhi MM; Mohamoud HS; Bakur K; Anshasi W; Wang J; Al-Aama JY
    Eur J Med Genet; 2015 Apr; 58(4):216-21. PubMed ID: 25721873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maladaptative Autophagy Impairs Adipose Function in Congenital Generalized Lipodystrophy due to Cavin-1 Deficiency.
    Salle-Teyssières L; Auclair M; Terro F; Nemani M; Elsayed SM; Elsobky E; Lathrop M; Délépine M; Lascols O; Capeau J; Magré J; Vigouroux C
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2892-904. PubMed ID: 27144934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital generalized lipodystrophy: a case report with neurological involvement].
    Ben Turkia H; Tebib N; Azzouz H; Abdelmoula MS; Ben Chehida A; Hubert P; Douira W; Ben Dridi MF
    Arch Pediatr; 2009 Jan; 16(1):27-31. PubMed ID: 19026526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmortem Findings in a Young Man With Congenital Generalized Lipodystrophy, Type 4 Due to CAVIN1 Mutations.
    Patni N; Vuitch F; Garg A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):957-960. PubMed ID: 30476128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGPAT2 gene mutation in a child with Berardinelli-Seip congenital lipodystrophy syndrome.
    Rostami P; Nakhaeimoghadam M; Bijani FM; Sotoudeh A; Rabbani A; Hilbert P; Rezaei N
    Ann Endocrinol (Paris); 2013 Feb; 74(1):59-61. PubMed ID: 23337016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood.
    Murakami N; Hayashi YK; Oto Y; Shiraishi M; Itabashi H; Kudo K; Nishino I; Nonaka I; Nagai T
    Neuromuscul Disord; 2013 May; 23(5):441-4. PubMed ID: 23489663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital generalized lipodystrophy: The evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4.
    Nilay Güneş ; Kutlu T; Tekant GT; Eroğlu AG; Üstündağ NÇ; Öztürk B; Onay H; Tüysüz B
    Eur J Med Genet; 2020 Apr; 63(4):103819. PubMed ID: 31778856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia.
    Karhan AN; Zammouri J; Auclair M; Capel E; Apaydin FD; Ates F; Verpont MC; Magré J; Fève B; Lascols O; Usta Y; Jéru I; Vigouroux C
    Eur J Endocrinol; 2021 Nov; 185(6):841-854. PubMed ID: 34643546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations.
    Nishiyama A; Yagi M; Awano H; Okizuka Y; Maeda T; Yoshida S; Takeshima Y; Matsuo M
    Pediatr Int; 2009 Dec; 51(6):775-9. PubMed ID: 19438831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berardinelli Seip Congenital Lipodystrophy Syndrome: 10 Year Follow-up.
    Joshi R; Sharma S
    Indian Pediatr; 2019 Oct; 56(10):877-878. PubMed ID: 31724546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.